Roche/Genentech’s Avastin takes another step forward toward an indication in ovarian cancer with the July 2 release of positive topline results from a second Phase III study showing an undisclosed benefit for progression free survival.
Continue reading "Coming In Monday's "The Pink Sheet" DAILY -- Avastin Moves Toward Ovarian Cancer Indication" »
ImmunoGen presents data at the American Society of Clinical Oncology's annual meeting on one of its growing number of internal compounds, IMGN388, in early development against solid tumors. The antibody conjugate company is building on positive results with trastuzumab-DM1, the Herceptin-based hybrid it built for Roche.
Continue reading "Coming In Tuesday's "The Pink Sheet" DAILY - DoJ, State AGs Call For Second Circuit To Rehear Cipro Case" »
The European Court of Justice handed generics firms a victory on Thursday when it ruled that UK doctors could legally be incentivized to prescribe cheaper drugs.
Continue reading "Coming In Monday's "The Pink Sheet" DAILY - Is An FDA Approval Of Provenge For Prostate Cancer Around The Corner? " »
In the first of a two-part interview, “The Pink Sheet” DAILY talks with King Pharmaceuticals CEO Brian Markison and Chief Scientific Officer Eric Carter about the company’s hopes for a wave of new drug formulations to treat chronic pain with lower abuse potential.
Continue reading "Coming in Monday's "The Pink Sheet" DAILY" »
Full article reprinted from "PharmAsia News" November 19, 2008
Read about why China's State FDA will launch a new fast-track mechanism by year end called the special approval procedure for drug registration to accelerate drug registration...
Continue reading "China Will Issue New Fast-Track Procedure For Drug Registration: CDE Official " »